# Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers

> **NCT02994732** · PHASE1 · COMPLETED · sponsor: **BioMed Valley Discoveries, Inc** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]-BVD-523

## Key facts

- **NCT ID:** NCT02994732
- **Lead sponsor:** BioMed Valley Discoveries, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-02
- **Final completion:** 2017-05-15
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994732, "Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02994732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*